215 related articles for article (PubMed ID: 2560431)
1. Stereospecific effects of a kappa-opiate antagonist on the actions of morphine in morphine-tolerant rats.
Bhargava HN; Kremer EK; Gibbons MO; Philips BJ; Driver JW; Chou M
Eur J Pharmacol; 1989 Dec; 173(2-3):159-64. PubMed ID: 2560431
[TBL] [Abstract][Full Text] [Related]
2. Effect of kappa-opioid receptor agonists on morphine analgesia in morphine-naive and morphine-tolerant rats.
Ramarao P; Jablonski HI; Rehder KR; Bhargava HN
Eur J Pharmacol; 1988 Nov; 156(2):239-46. PubMed ID: 2853674
[TBL] [Abstract][Full Text] [Related]
3. The effect of U-50,488H, a kappa-opiate receptor agonist on tolerance to the analgesic and hyperthermic effects of morphine in the rat.
Bhargava HN; Matwyshyn G; Ramarao P
Gen Pharmacol; 1991; 22(3):429-34. PubMed ID: 1651266
[TBL] [Abstract][Full Text] [Related]
4. Analgesic and discriminative stimulus properties of U-62,066E, the selective kappa-opioid receptor agonist, in the rat.
Ohno M; Yamamoto T; Ueki S
Psychopharmacology (Berl); 1992; 106(1):31-8. PubMed ID: 1346721
[TBL] [Abstract][Full Text] [Related]
5. Kappa antagonist properties of buprenorphine in non-tolerant and morphine-tolerant rats.
Negus SS; Picker MJ; Dykstra LA
Psychopharmacology (Berl); 1989; 98(1):141-3. PubMed ID: 2543017
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
Gistrak MA; Paul D; Hahn EF; Pasternak GW
J Pharmacol Exp Ther; 1989 Nov; 251(2):469-76. PubMed ID: 2553921
[TBL] [Abstract][Full Text] [Related]
7. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist.
Bhargava HN; Ramarao P; Gulati A
Eur J Pharmacol; 1989 Mar; 162(2):257-64. PubMed ID: 2542058
[TBL] [Abstract][Full Text] [Related]
8. Stereospecific opiate receptors in the actions of thyrotropin releasing hormone and morphine on gastrointestinal transit.
Bhargava HN; Pillai NP
Life Sci; 1985 Jan; 36(1):83-8. PubMed ID: 2981381
[TBL] [Abstract][Full Text] [Related]
9. Involvement of opioid receptors in hypo- and hyperthermic effects induced by phencyclidine in mice.
Hiramatsu M; Nabeshima T; Kameyama T
J Pharmacobiodyn; 1986 May; 9(5):466-72. PubMed ID: 3020223
[TBL] [Abstract][Full Text] [Related]
10. Kappa-receptor antagonist reverse 'non-opioid' stress-induced analgesia.
Panerai AE; Martini A; Sacerdote P; Mantegazza P
Brain Res; 1984 Jun; 304(1):153-6. PubMed ID: 6331578
[TBL] [Abstract][Full Text] [Related]
11. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat.
Iyengar S; Kim HS; Wood PL
J Pharmacol Exp Ther; 1986 Aug; 238(2):429-36. PubMed ID: 3016237
[TBL] [Abstract][Full Text] [Related]
12. kappa-Opioid receptor agonist protects against ischemic reduction of 2-deoxyglucose uptake in morphine-tolerant rats.
Shibata S; Tominaga K; Watanabe S
Eur J Pharmacol; 1995 Jun; 279(2-3):197-202. PubMed ID: 7556401
[TBL] [Abstract][Full Text] [Related]
13. Role of kappa and delta opioid receptors in mediating morphine-induced antinociception in morphine-tolerant infant rats.
Stoller DC; Sim-Selley LJ; Smith FL
Brain Res; 2007 Apr; 1142():28-36. PubMed ID: 17300766
[TBL] [Abstract][Full Text] [Related]
14. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
15. Antagonistic effect of MR2266 and MR2267 on morphine or nalbuphine analgesia at the spinal levels in rats.
Kmieciak-Kołada K; Spiewak Z; Urbanowicz A; Pawłowski J; Herman ZS
Pol J Pharmacol; 1995; 47(6):509-18. PubMed ID: 8868373
[TBL] [Abstract][Full Text] [Related]
16. The effect of Panax ginseng on the development of tolerance to the pharmacological actions of morphine in the rat.
Bhargava HN; Ramarao P
Gen Pharmacol; 1991; 22(3):521-5. PubMed ID: 1869026
[TBL] [Abstract][Full Text] [Related]
17. Estimation in vivo of the receptor constants of morphine in naive and morphine-tolerant rats.
Porreca F; Cowan A; Raffa RB; Tallarida RJ
Life Sci; 1982 Nov 15-22; 31(20-21):2355-8. PubMed ID: 6298527
[TBL] [Abstract][Full Text] [Related]
18. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
[TBL] [Abstract][Full Text] [Related]
19. Central kappa- and mu-opiate receptors mediate ACTH-release in rats.
Pfeiffer A; Herz A; Loriaux DL; Pfeiffer DG
Endocrinology; 1985 Jun; 116(6):2688-90. PubMed ID: 2986960
[TBL] [Abstract][Full Text] [Related]
20. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
Yamamoto T; Ohno M; Ueki S
Eur J Pharmacol; 1988 Oct; 156(1):173-6. PubMed ID: 2850208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
